📄Find here the Joint Statement for an Ambitious FP10: Investing in Europe’s Future Competitiveness through Collaborative Research, Development, and Innovation. The joint statement was developed by the European Association of Research and Technology Organisations (EARTO), along with 110 partner signatories, urging an increase in the future FP10 budget and pan-European collaborative research.
📄Find here MedTech Europe’s contribution to the consultation launched by the European Commission’s expert group on the interim evaluation of Horizon Europe. The consultations will contribute to a report which will be produced by the expert group on how the EU Framework Programme for R&I can continue to add value for the remainder of Horizon Europe and in the future. Â
📄Find here MedTech Europe’s response statement to the Heitor Expert Group Report on Horizon Europe. We support numerous recommendations proposed by the Expert Group, in particular, those calling for stronger European competitive excellence in Research and Innovation (R&I), simplification, and its recognition of the need to bolster the EU’s capacity to innovate and lead in the area of health. We also welcome the acknowledgement of the importance of the Life Sciences sector within Europe’s R&I ecosystem as an area ripe for investment and synergies. The emphasis on fostering an attractive and inclusive R&I ecosystem resonates with our commitment to work cooperatively with public and private partners to strengthen Europe’s competitiveness.